References
- Nowell P C, Hungerford D A. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497
- Rowley J D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293
- Soma S, Sandberg A A. Chromosomes and causation of human cancer and leukemia: XXVIII. Value of detailed chromosome studies on large numbers of cells in CML. Am J Hematol 1977; 3: 121–126
- deKlein A, van Kessel A G, Grosveld G, et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 1982; 300: 763
- Groffen J, Stephenson J R, Heisterkamp N, et al. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93
- Heisterkamp N, Groffen J, Stephenson N K. The human v-abl cellular homologue. J Mol Appl Genet 1983; 12: 57–68
- Konopka J B, Watanabe S M, Singer J W, et al. Cell lines and clinical isolates derived from Ph-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alterations. Proc Natl Acad Sci (USA) 1985; 82: 1810–1816
- Kloetzer W, Kurzrock R, Smith L, et al. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine kinase activity. Virology 1985; 140: 230–238
- Thomas E D, Clift R, Fefer A, et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986; 104: 155–163
- Fefer A, Cheever M A, Greenberg P D, et al. Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins. N Engl J Med 1982; 306: 63–68
- Niederle N, Doberauer C, Kloke O, et al. Treatment of chronic myelogenous leukemia with recombinant interferon-alpha (IFN-alpha2B). Proc Am Sec Clin Oncol 1986; 5: 236–925